The results showed that the number of CD3+CD56+ T lymphocytes was increased in primary AL patients (AML and ALL patients), while the levels of CD1d on monocytes were decreased in primary AL patients. The gene discussed is NCAM1; the disease is acute lymphoblastic leukemia.